SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today ...
WALTHAM, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF) today announced the presentation of new preclinical data in the MORF-057 IBD development program that are consistent ...
The FDA has approved golimumab-sldi as the first interchangeable biosimilar to Simponi for ulcerative colitis. Golimumab-sldi ...
Higher consumption of dietary fiber was associated with a lower risk for inflammatory bowel disease (IBD), according to a study published online July 18 in Alimentary Pharmacology and Therapeutics.
LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who achieved disease clearance at one year maintained composite disease clearance ...
Learn how to cope with grief post-diagnosis with these tips from experts and one woman with ulcerative colitis.
Both Crohn's disease and ulcerative colitis are forms of inflammatory bowel disease (IBD) and share similar symptoms. Crohn's disease can cause inflammation anywhere from your mouth to your anus, ...
SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio ...
Getty Images Understanding current trends in the incidence, prevalence, and distribution of ulcerative colitis can help inform diagnosis and treatment. Most incidence and prevalence studies for UC ...
A new drug, investigated by Amsterdam University Medical Centers together with colleagues around the world, is effective as a treatment against ulcerative colitis. With the clinical trial ...
Omvoh is a biologic medicine used to treat moderate to severe ulcerative colitis. Ulcerative colitis is an inflammatory bowel disease that causes inflammation in parts of the digestive tract. Common ...